Muscular Dystrophies Clinical Trial
Official title:
Self-management Training for Parents With Chronic Muscular Dystrophia
The relentless progressive process of muscular dystrophy requires extraordinary medical, physical, and emotional care with severe consequences for caring parents (increased stress and diminished social, psychological and physical well-being). Despite the obvious need of support for parents only few and weak data exist regarding efficiency and efficacy of specific interventions supporting parental resilience and coping strategies. The presenting study aims to fill this gap by evaluating the efficacy of a structured self-management training for parents of children with severe progressive muscular dystrophy compared to parents receiving treatment as usual (TAU). In addition, investigators measure established biomarkers of psychosocial stress, such as pro-inflammatory cytokines, which will be used to monitor physiological changes with assumed significance for parental health.
Background:
The relentless progressive process of muscular dystrophy requires extraordinary medical,
physical, and emotional care. As a consequences caring for a patient with a severe chronic
illness has been associated with increased stress and diminished social, psychological and
physical well-being in parents. According to Thompson et al. 57% of parents with Duchenne
muscular dystrophy children have self-reported poor psychological adjustment and, even in
comparison with parents of children with other burdens like cerebral palsy or renal diseases,
muscular dystrophy was associated with a wider spectrum of problems and parental stress.
Moreover, parents are shown to have significant stress by feelings of guilt and associated
difficulty discussing death issues with their children.
However, despite the obvious need of support for parents only few and weak data exist
regarding efficiency and efficacy of specific interventions supporting parental resilience
and coping strategies. In practice, they are mostly limited to meetings of self-help groups
and casual exchange between concerned parents, which is rather a problem-centered than
proactive solution-focused approach. As a consequence, investigators see a great need for
studies regarding more specific interventions supporting parents' self-management skills,
coping strategies and competencies.
Objectives:
The present study evaluates the efficacy of a structured self-management training for parents
of children with severe progressive muscular dystrophy compared to parents receiving
treatment as usual (TAU). In addition, investigators measure established biomarkers of
psychosocial stress, such as pro-inflammatory cytokines, which will be used to monitor
physiological changes with assumed significance for parental health.
Methods:
Participants will fill out online-questionnaires before, during and after self-management
training. Training interventions will take place in Zurich as group sessions (10-20
participants per group). Investigators aim for a total of 60-80 participants. Parent-couples
or single participants will be randomized in an intervention group (participants receiving
self-management training) and a non-intervention group (participants continue with already
established support). After one year parents from the non-intervention group will change into
the intervention group with self- management training as well. Questionnaires focus on
assessing parental strain and self- efficacy and will take 30-45minutes for each of four
surveys. Validated biological markers such as cumulative cortisol levels in hair and
pro-inflammatory cytokines in the blood will be collected before and after self-management
trainings.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT01480245 -
Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
|
Phase 3 | |
| Completed |
NCT01153932 -
Phase II Doubleblind Exploratory Study of GSK2402968 in Ambulant Subjects With Duchenne Muscular Dystrophy
|
Phase 2 | |
| Completed |
NCT00027391 -
Study of Albuterol and Oxandrolone in Patients With Facioscapulohumeral Dystrophy (FSHD)
|
N/A | |
| Recruiting |
NCT04392518 -
Telerehabilitation in Proximal Muscle Weakness
|
N/A | |
| Completed |
NCT03851107 -
The Effectiveness of Participation-focused Interventions on Body Functions of Youth With Physical Disabilities
|
N/A | |
| Completed |
NCT01462292 -
A Clinical Study to Assess Two Doses of GSK2402968 in Subjects With Duchenne Muscular Dystrophy (DMD)
|
Phase 2 | |
| Recruiting |
NCT06094205 -
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia (BG-Speech-02)
|
N/A | |
| Recruiting |
NCT05724173 -
Feasibility of the BrainGate2 Neural Interface System in Persons With Tetraplegia
|
N/A | |
| Recruiting |
NCT03698149 -
ECoG BMI for Motor and Speech Control
|
N/A | |
| Active, not recruiting |
NCT03811301 -
[BrainConnexion] - Neurodevice Phase I Trial
|
N/A | |
| Completed |
NCT05881122 -
Anti-inflammatory Diet Consultation for Those With Neuromuscular Disability
|
N/A | |
| Completed |
NCT04154098 -
Evaluation of a Textile Scapula Orthosis
|
N/A | |
| Recruiting |
NCT05409079 -
Schulze Muscular Dystrophy Ability Clinical Study
|
N/A | |
| Enrolling by invitation |
NCT04009408 -
Expiratory Muscle Strength Training (EMST) in Neuromuscular Disorders
|
N/A | |
| Active, not recruiting |
NCT00674843 -
The Efficacy of Using Far Infrared Radiation to Manage Muscular Dystrophies
|
Phase 1 | |
| Recruiting |
NCT02109692 -
Evaluation of Muscle miRNA as Biomarkers in Dystrophinopathies
|
N/A | |
| Active, not recruiting |
NCT04045158 -
Diaphragm Ultrasound in Neuromuscular Disorders
|
||
| Not yet recruiting |
NCT03508583 -
Turkish Version of The Measure of Processes of Care (MPOC)
|
||
| Terminated |
NCT01803412 -
A Study of the Safety, Tolerability & Efficacy of Long-term Administration of Drisapersen in US & Canadian Subjects
|
Phase 3 | |
| Completed |
NCT03406780 -
A Study of CAP-1002 in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
|
Phase 2 |